Ninety One (UK)
ZBH icon

Ninety One (UK)’s Zimmer Biomet ZBH Stock Holding History

Ninety One (UK)’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-672,891
Closed -$83.4M – 282
2019
Q1 		$83.4M Sell
672,891
-5,348
-0.8% -$608K 0.33% 78
2018
Q4 		$68.3M Buy
678,239
+48,172
+8% +$5.42M 0.29% 92
2018
Q3 		$80.4M Buy
630,067
+400,007
+174% +$47.6M 0.3% 88
2018
Q2 		$24.9M Sell
230,060
-43,542
-16% -$4.74M 0.12% 115
2018
Q1 		$29M Sell
273,602
-149,591
-35% -$17.4M 0.16% 113
2017
Q4 		$49.6M Sell
423,193
-34,735
-8% -$3.93M 0.2% 102
2017
Q3 		$52.1M Sell
457,928
-1,627,142
-78% -$188M 0.23% 94
2017
Q2 		$260M Sell
2,085,070
-45,577
-2% -$5.4M 1.24% 20
2017
Q1 		$253M Sell
2,130,647
-58,274
-3% -$6.6M 1.25% 19
2016
Q4 		$219M Buy
2,188,921
+11,479
+0.5% +$1.23M 1.15% 24
2016
Q3 		$275M Buy
2,177,442
+2,758
+0.1% +$341K 1.34% 17
2016
Q2 		$254M Sell
2,174,684
-111,002
-5% -$12.6M 1.31% 17
2016
Q1 		$237M Sell
2,285,686
-26,148
-1% -$2.53M 1.28% 19
2015
Q4 		$230M Buy
2,311,834
+39,668
+2% +$3.88M 1.31% 21
2015
Q3 		$207M Sell
2,272,166
-21,474
-0.9% -$2.15M 1.3% 22
2015
Q2 		$243M Sell
2,293,640
-50,841
-2% -$5.63M 1.39% 19
2015
Q1 		$267M Buy
2,344,481
+73,814
+3% +$8.42M 1.56% 14
2014
Q4 		$250M Sell
2,270,667
-6,284
-0.3% -$662K 1.53% 10
2014
Q3 		$222M Sell
2,276,951
-8,771
-0.4% -$863K 1.31% 18
2014
Q2 		$230M Buy
2,285,722
+163,106
+8% +$15.9M 1.34% 16
2014
Q1 		$195M Buy
2,122,616
+22,211
+1% +$2.05M 1.3% 22
2013
Q4 		$190M Buy
2,100,405
+51,883
+3% +$4.49M 1.33% 21
2013
Q3 		$163M Sell
2,048,522
-64,555
-3% -$5.08M 1.2% 23
2013
Q2 		$154M Buy
+2,113,077
New +$158M 1.18% 21

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Ninety One (UK)'s ZBH Position: Q2 2019 in Review

Ninety One (UK) sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 672,891 shares — an estimated $83.4M sold.

Ninety One (UK) first reported a position in ZBH in Q2 2013 and held it in 24 quarters. The position peaked at $275M in Q3 2016. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

  • Ninety One (UK) reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
  • Ninety One (UK) sold 672,891 Zimmer Biomet shares in Q2 2019, an estimated $83.4M.
  • Ninety One (UK) first reported a position in Zimmer Biomet in Q2 2013 and held it in 24 quarters.
  • Ninety One (UK)'s Zimmer Biomet position peaked at $275M in Q3 2016.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Ninety One (UK)'s 13F filing for Q2 2019, filed 30 Jul 2019.